PJ Barter, CM Ballantyne, R Carmena, MC … - Journal of internal medicine, 2006 - interscience.wiley.com It is also possible that your web browser is not configured or not able to
display style sheets. In this case, although the visual presentation will be
degraded, the site should continue to be functional. We recommend using the ... Cited by 143 - Related articles - BL Direct - All 7 versions
B Fagerberg, S Edwards, T Halmos, J … - Diabetologia, 2005 - Springer Page 1. Diabetologia (2005) 48: 1716–1725 DOI 10.1007/s00125-005-1846-8 ARTICLE
B. Fagerberg . S. Edwards . T. Halmos . J. Lopatynski . H. Schuster . ... Cited by 72 - Related articles - All 5 versions
- ►onlinejacc.org JD Brunzell, M Davidson, CD Furberg, RB … - Diabetes Care, 2008 - Am Diabetes Assoc Risk factors for type 2 diabetes and cardiovascular disease (CVD) often cluster,
including obesity (particularly central), insulin resistance, hyperglycemia,
dyslipoproteinemia, and hypertension. These conditions can also occur in ... Cited by 64 - Related articles - All 22 versions
- Free from Publisher JD Brunzell, M Davidson, CD Furberg, RB … - Diabetes Care, 2008 - ncbi.nlm.nih.gov 1: Diabetes Care. 2008 Apr;31(4):811-22. Lipoprotein management in patients
with cardiometabolic risk: consensus statement from ... Cited by 52 - Related articles - BL Direct - All 2 versions
- ►ahajournals.org AD Sniderman - Circulation, 2005 - Am Heart Assoc Vascular disease is already the most common cause of death in the developed
world and by 2020 will become the leading cause of death in the developing world
as well. 1 No society can afford to offer everyone every therapy. ... Cited by 43 - Related articles - All 5 versions
KC Sung, ST Hwang - Atherosclerosis, 2005 - Elsevier Insulin resistance (IR) is associated with a significant increase in the risk of
coronary artery disease (CAD). The serum apolipoprotein B and Apo A1/Apo B ratio
are important markers of CAD. The aim of this study was to assess the ... Cited by 18 - Related articles - All 7 versions
AD Sniderman, SM Marcovina - Clinics in laboratory medicine, 2006 - Elsevier However, the cholesterol model was developed and widely applied before the
variable composition of the major proatherogenic lipoproteins
(very–low-density lipoprotein [VLDL] and LDL) became apparent. For ... Cited by 15 - Related articles - All 3 versions
MP Solano, RB Goldberg - Cardiology in Review, 2006 - journals.lww.com Diabetes is associated with a high risk of cardiovascular disease. The
management of dyslipidemia, a well-recognized and modifiable risk factor among
patients with type 2 diabetes, is an important element in the ... Cited by 13 - Related articles - BL Direct - All 4 versions
G Bruno, F Merletti, A Biggeri, G Bargero, S … - Diabetologia, 2006 - Springer Page 1. Diabetologia (2006) 49: 937–944 DOI 10.1007/s00125-006-0195-6 ARTICLE G.
Bruno . F. Merletti . A. Biggeri . G. Bargero . S. Prina-Cerai . G. Pagano . ... Cited by 11 - Related articles - BL Direct - All 3 versions
M Del Pilar Solano, RB Goldberg - Endocrinology and metabolism clinics of North America, 2005 - Elsevier Cardiovascular disease (CVD) is a major cause of morbidity and mortality among
subjects who have diabetes. It is estimated that cardiovascular complications
are responsible for up to 75% of deaths among people who have type 2 ... Cited by 10 - Related articles - All 3 versions
